Individual variability in barriers affecting people's decision to take HAART: A qualitative study identifying barriers to being on HAART

AIDS Patient Care and STDs

Volumn 20, Issue 12, 2006, Pages 848-857

  Alfonso, Victoria ^a,b   Bermbach, Nicole ^a   Geller, Josie ^a   Montaner, Julio S G ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RITONAVIR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DECISION MAKING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIVIDUALITY; MALE; MOOD; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; TREATMENT REFUSAL; URBAN AREA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANADA; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; TREATMENT REFUSAL; URBAN POPULATION;

EID: 33846239368     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.848     Document Type: Article

References (22)

1. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450-545.
2. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000;356:291-296.
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
4. Bassetti S, Battegay M, Furrer H, et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? J Acquir Immune Defic Syndr 1999;21:144-119.
5. Strathdee SA, Palepu A, Cornelisse PGA, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547-549.
6. Kremer H, Bader A, O'Cleirigh C, Bierhoff HW, Brockmeyer NH. The decision to forgo antiretroviral therapy in people living with HIV-Compliance as paternalism or partnership? Eur J Med Res 2004;9:61-70.
7. Maisels L, Steinberg J, Tobias C. An investigation of why eligible patients do not receive HAART. AIDS Patient Care and STDs 2001;15:185-191.
8. Gold RS, Hinchy J, Batrouney CG. The reasoning behind decisions not to take up antiretroviral therapy in Australians infected with HIV. Int J STD AIDS 2000;11:361-370.
9. Gold RS, Ridge DT. "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001;13:693-708.
10. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286:2568-2577.
11. Yeni PG, Hammer SM, Carpenter CCJ, et al. Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel. JAMA 2002;288:222-235.
12. Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004;292:251-265.
13. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385-401.
14. Flanagan JC. The critical incident technique. Psychol Bull 1954;51:327-358.
15. Kemppainen JK, Levine RE, Buffman M, Holzemer WL, Finley P, Jensen P. Antiretroviral adherence in persons with HIV/AIDS and severe mental illness. J Nerv Ment Dis 2004;192:395-404.
16. Alfonso V, Geller J, Bermbach N, Drummond A, Montaner JSG. Becoming a "treatment success": What helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care STDs 2006;20:326-334.
17. Alfonso V, Montaner JSG, Ishiyama I. Adherence to anti-HIV regimen: What helps and what hinders it? Paper presented at: The Canadian Association of HIV/AIDS Research Conference. Montreal, Canada: 2000.
18. Kemppainen JK, Levine RE, Mistal M, Schmidgall, D. HAART adherence in culturally diverse patients with HIV/AIDS: A study of male patients from a Veteran's Administration hospital in Northern California. AIDS Patient Care STDs 2001;15:117-127.
19. Kent G, Wills G, Faulkner A, Parry G, Whipp M, Coleman R. Patient reactions to met and unmet psychological need: A critical incident analysis. Patient Educ Couns 1996;28:187-190.
20. Kalichman S. Understanding AIDS: A Guide for Mental Health Professionals. Washington, D.C.: American Psychological Association, 1995.
21. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. New York, NY: The Guilford Press; 2002.
22. Fairfield KM, Libman H, Davis RB, Eisenberg DM, Phillips RS. Delays in protease inhibitor use in clinical practice. J Gen Intern Med 1999;14:395-401.